Clinical Study
Combined Epidermal Growth Factor Receptor and Beclin1 Autophagic Protein Expression Analysis Identifies Different Clinical Presentations, Responses to Chemo- and Radiotherapy, and Prognosis in Glioblastoma
Figure 3
Patient with L-EGFR (a) and L-Beclin1 (b) pattern of protein expression in GB. The arrows indicate the endothelium of vessels, negative for EGFR (a) and positive for Beclin1 (b) Immunohistochemistry, diaminobenzidine, original magnification ×200. (c) MRI T1-sequence with gadolinium shows a right temporal lesion (white arrow) before treatment. (d) Radiological progression (white arrow) after treatment (MRI at 6 months after adjuvant RT-CHT treatment).
(a) |
(b) |
(c) |
(d) |